BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
about
A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease.Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.Assessment of BRAF(V600E) mutation in pulmonary Langerhans cell histiocytosis in tissue biopsies and bronchoalveolar lavages by droplet digital polymerase chain reaction.Salvage treatment of relapsed/refractory LCHNew somatic BRAF splicing mutation in Langerhans cell histiocytosis.Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAFV600E mutations in adult populations.Adult-onset Langerhans cell histiocytosis of the sternum.The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis.Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement.Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature.
P2860
Q38602233-0A08EF5C-2708-4DDF-BC09-BB8701D4BF07Q40464058-B4DC495D-2EA6-494C-8C42-F8237941BF48Q40486824-CBC2DE6B-8DD9-41CA-9FD8-425D6FC17F18Q42195584-26EE92B5-273B-4546-B054-4D1B06160FD9Q42331849-65E393D6-5CF0-475A-8F78-A7C189DA172CQ42774672-2C1C8F92-0C1E-4D62-A648-851AC4DF02EDQ44195415-3526CBD0-3FD1-40E7-A719-E260A7ABAB2FQ47129503-129460DE-325E-43E3-A5FA-3602789077F3Q48217203-9A1873C2-4BAB-41AA-9CFE-724A84375218Q50056461-49AF9636-84D8-4391-BF6E-D25E4541EC9CQ55042378-08626F79-0EFB-49A5-A6C8-5EA8A2C0E618
P2860
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BRAF Mutation Correlates With ...... istance to First-Line Therapy.
@en
BRAF Mutation Correlates With ...... istance to First-Line Therapy.
@nl
type
label
BRAF Mutation Correlates With ...... istance to First-Line Therapy.
@en
BRAF Mutation Correlates With ...... istance to First-Line Therapy.
@nl
prefLabel
BRAF Mutation Correlates With ...... istance to First-Line Therapy.
@en
BRAF Mutation Correlates With ...... istance to First-Line Therapy.
@nl
P2093
P2860
P50
P356
P1476
BRAF Mutation Correlates With ...... istance to First-Line Therapy.
@en
P2093
Alina Ferster
Anne Deville
Anne Lambilliotte
Anne Lutun
Anne Moreau
Brigitte Lescoeur
Caroline Thomas
Catherine Chassagne-Clément
Catherine Paillard
Christine Bodemer
P2860
P304
P356
10.1200/JCO.2015.65.9508
P407
P577
2016-07-05T00:00:00Z